gip glp 1 agonist tirzepatide Main physiological actions of the dual and GLP-1 TrimRX | GLP-1 vs GIP:

Curr Alzheimer Res

However, the use of this medication requires a prolonged initial treatment period of dose-escalation to attenuate the adverse gastrointestinal effects (nausea, vomiting, diarrhea) typically associated with GLP-1R agonists, which still occurred frequently but rarely resulted in discontinuation of treatment

The Advantage of Higher Bioavailability Injectable medications offer higher bioavailability, whether were discussing semaglutide, tirzepatide, or liraglutide

13 CummingsJ

L.LeeN.ThakurtaS.ChanB

SGLT2 inhibitors are preferred in people with HF or at high-risk for HF, whereas GLP-1 receptor agonists are favored for those requiring significant weight loss, ASCVD risk reduction, CKD management, or in whom mitigation of metabolic dysfunction-associated steatotic liver disease (MASLD) or steatohepatitis is a clinical priority [84]